GEN1042 Safety Trial and Anti-tumor Activity in Subjects With Malignant Solid Tumors
Trial status:Recruiting
Study Identifier:
GCT1042-01
ClinicalTrials.gov Identifier:
EudraCT Identifier:
Sponsor:
The sponsor of a clinical trial is the company, institution or individual that takes responsibility for initiating, managing, and/or financing a clinical investigation. BioNTech collaborates with other pharmaceutical companies or institutions (collaborators) to develop certain new medicines. In particular cases BioNTech's collaborators are leading specific clinical trials and are acting as sponsors accordingly.
Genmab
Recruiting
Trial details
Medical Condition
Study Drug
See more
Phase
Phase 1
Sex
Female & Male
Age
18+
Estimated Trial Date
Sep 2019 - Jul 2025
Protocol summary
To evaluate the safety and anti-tumor activity of GEN1042 in patients with metastatic or locally advanced solid tumors.
Trial locations
Location
Status
Location
Alaska Oncology and Hematology LLC
Anchorage, Alaska, United States, 99508
Status
Recruiting
Location
Cancer & Blood Specialty Clinic
Los Alamitos, California, United States, 90720
Status
Recruiting
Location
Moores Cancer Center at the UC San Diego Health
San Diego, California, United States, 92037
Status
Recruiting
Location
Yale University Cancer Center
New Haven, Connecticut, United States, 06520
Status
Recruiting
Location
ChristianaCare
Newark, Delaware, United States, 19713
Status
Recruiting
Location
Mount Sinai Comprehensive Cancer Center
Miami Beach, Florida, United States, 33140
Status
Recruiting